Atara has just announced a CRL by FDA for EBVALLO. EBVALLO is already approved in Europe since December 2022 and the cause of the CRL seems minor and easily addressable. The CRL has a major impact on ...
Investors in Charles River Laboratories International Inc. (Symbol: CRL) saw new options become available today, for the August 2025 expiration. One of the key inputs that goes into the price an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results